We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disord... Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin. Show more
NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQ: DRUG), a biotechnology company focused on...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER...
BMB-201 demonstrated dose-dependent efficacy in pain modelsBMB-201 demonstrated similar efficacy to morphine in several pain models NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bright Minds...
TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.69 | -5.28487229862 | 50.9 | 52.75 | 40.94 | 677525 | 47.4925733 | CS |
4 | 47.1 | 4243.24324324 | 1.11 | 79.02 | 0.94 | 9225181 | 35.56701168 | CS |
12 | 47.12 | 4322.93577982 | 1.09 | 79.02 | 0.94 | 3224745 | 34.53090446 | CS |
26 | 47.25 | 4921.875 | 0.96 | 79.02 | 0.9305 | 1509941 | 34.26917184 | CS |
52 | 46.87 | 3497.76119403 | 1.34 | 79.02 | 0.93 | 777886 | 33.68586501 | CS |
156 | 3.46 | 7.73184357542 | 44.75 | 79.02 | 0.93 | 1489003 | 14.46015536 | CS |
260 | 3.46 | 7.73184357542 | 44.75 | 79.02 | 0.93 | 1489003 | 14.46015536 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions